Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 367

1.

Epigenetic modification in histone deacetylase deletion strain of Calcarisporium arbuscula leads to diverse diterpenoids.

Bai J, Mu R, Dou M, Yan D, Liu B, Wei Q, Wan J, Tang Y, Hu Y.

Acta Pharm Sin B. 2018 Jul;8(4):687-697. doi: 10.1016/j.apsb.2017.12.012. Epub 2018 Feb 21.

2.

Biocatalytic access to diverse prenylflavonoids by combining a regiospecific C-prenyltransferase and a stereospecific chalcone isomerase.

Li J, Chen R, Wang R, Liu X, Xie K, Chen D, Dai J.

Acta Pharm Sin B. 2018 Jul;8(4):678-686. doi: 10.1016/j.apsb.2018.01.009. Epub 2018 Mar 5.

3.

Genome-wide characterization and analysis of bHLH transcription factors in Panax ginseng.

Chu Y, Xiao S, Su H, Liao B, Zhang J, Xu J, Chen S.

Acta Pharm Sin B. 2018 Jul;8(4):666-677. doi: 10.1016/j.apsb.2018.04.004. Epub 2018 Apr 12.

4.

In situ monitoring of the structural change of microemulsions in simulated gastrointestinal conditions by SAXS and FRET.

Lv X, Zhang S, Ma H, Dong P, Ma X, Xu M, Tian Y, Tang Z, Peng J, Chen H, Zhang J.

Acta Pharm Sin B. 2018 Jul;8(4):655-665. doi: 10.1016/j.apsb.2018.05.008. Epub 2018 May 23.

5.

Authentic compound-free strategy for simultaneous determination of primary coumarins in Peucedani Radix using offline high performance liquid chromatography-nuclear magnetic resonance spectroscopy-tandem mass spectrometry.

Liu Y, Song Q, Liu W, Li P, Li J, Zhao Y, Zhang L, Tu P, Wang Y, Song Y.

Acta Pharm Sin B. 2018 Jul;8(4):645-654. doi: 10.1016/j.apsb.2018.01.005. Epub 2018 Feb 21.

6.

Limonoids from seeds of Azadirachta indica A. Juss. and their cytotoxic activity.

Chen J, Fan X, Zhu J, Song L, Li Z, Lin F, Yu R, Xu H, Zi J.

Acta Pharm Sin B. 2018 Jul;8(4):639-644. doi: 10.1016/j.apsb.2017.12.009. Epub 2018 Feb 1.

7.

Synthesis and biological evaluation of novel tricyclic matrinic derivatives as potential anti-filovirus agents.

Zhang X, Liu Q, Li Q, Li Y, Liu Z, Deng H, Tang S, Wang Y, Wang Y, Song D.

Acta Pharm Sin B. 2018 Jul;8(4):629-638. doi: 10.1016/j.apsb.2018.01.006. Epub 2018 Feb 21.

8.

Structure-based design, synthesis, and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors.

Wu XN, Huang YD, Li JX, Yu YF, Qian Z, Zhang C, Wu Y, Luo HB.

Acta Pharm Sin B. 2018 Jul;8(4):615-628. doi: 10.1016/j.apsb.2017.12.007. Epub 2018 Mar 12.

9.

Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer.

Chowdhury P, Nagesh PKB, Khan S, Hafeez BB, Chauhan SC, Jaggi M, Yallapu MM.

Acta Pharm Sin B. 2018 Jul;8(4):602-614. doi: 10.1016/j.apsb.2017.10.004. Epub 2017 Dec 10.

10.

Gold nanorods together with HSP inhibitor-VER-155008 micelles for colon cancer mild-temperature photothermal therapy.

Tang X, Tan L, Shi K, Peng J, Xiao Y, Li W, Chen L, Yang Q, Qian Z.

Acta Pharm Sin B. 2018 Jul;8(4):587-601. doi: 10.1016/j.apsb.2018.05.011. Epub 2018 Jun 5.

11.

Garlic-derived compound S-allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway.

Xiao J, Xing F, Liu Y, Lv Y, Wang X, Ling MT, Gao H, Ouyang S, Yang M, Zhu J, Xia Y, So KF, Tipoe GL.

Acta Pharm Sin B. 2018 Jul;8(4):575-586. doi: 10.1016/j.apsb.2017.10.003. Epub 2017 Nov 10.

12.

Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 in vitro and in vivo.

Zhang Z, Guo X, To KKW, Chen Z, Fang X, Luo M, Ma C, Xu J, Yan S, Fu L.

Acta Pharm Sin B. 2018 Jul;8(4):563-574. doi: 10.1016/j.apsb.2018.06.002. Epub 2018 Jun 15.

13.

Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy.

Liu F, Yang X, Geng M, Huang M.

Acta Pharm Sin B. 2018 Jul;8(4):552-562. doi: 10.1016/j.apsb.2018.01.008. Epub 2018 Feb 16. Review.

14.

The application of CAR-T cell therapy in hematological malignancies: advantages and challenges.

Zhao Z, Chen Y, Francisco NM, Zhang Y, Wu M.

Acta Pharm Sin B. 2018 Jul;8(4):539-551. doi: 10.1016/j.apsb.2018.03.001. Epub 2018 Apr 5. Review.

15.

Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective.

Jiang W, Cai G, Hu PC, Wang Y.

Acta Pharm Sin B. 2018 Jul;8(4):530-538. doi: 10.1016/j.apsb.2018.04.005. Epub 2018 Apr 30. Review.

16.

Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies.

Bumbaca B, Li W.

Acta Pharm Sin B. 2018 Jul;8(4):518-529. doi: 10.1016/j.apsb.2018.04.007. Epub 2018 Apr 30. Review.

17.

Targeting an oncogenic kinase/phosphatase signaling network for cancer therapy.

Qi XM, Wang F, Mortensen M, Wertz R, Chen G.

Acta Pharm Sin B. 2018 Jul;8(4):511-517. doi: 10.1016/j.apsb.2018.05.007. Epub 2018 May 22. Review.

18.

Understanding the biology of HER3 receptor as a therapeutic target in human cancer.

Lyu H, Han A, Polsdofer E, Liu S, Liu B.

Acta Pharm Sin B. 2018 Jul;8(4):503-510. doi: 10.1016/j.apsb.2018.05.010. Epub 2018 Jun 2. Review.

19.

Editorial Preface for Targeted Cancer Therapy.

Chen G, Li W.

Acta Pharm Sin B. 2018 Jul;8(4):501-502. doi: 10.1016/j.apsb.2018.07.003. Epub 2018 Jul 25. No abstract available.

20.

Editor Profiles: Guest Editor of Special Column on Targeted Cancer Therapy.

[No authors listed]

Acta Pharm Sin B. 2018 Jul;8(4):499-500. doi: 10.1016/j.apsb.2018.07.002. Epub 2018 Jul 25. No abstract available.

Supplemental Content

Loading ...
Support Center